DNA damage tumor suppressor genes and genomic instability

Current Opinion in Genetics and Development

Volumn 14, Issue 1, 2004, Pages 11-16

  Motoyama, Noboru ^a   Naka, Kazuhito ^a,b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE H2A; PROTEIN KINASE; PROTEIN P53;

APOPTOSIS; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; CHROMOSOME STRUCTURE; DNA DAMAGE; DNA REPAIR; HUMAN; MICROSATELLITE INSTABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0842287638     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2003.12.003     Document Type: Review

References (41)

1. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168.
2. O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., Goodship J.A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33:2003;497-501.
3. Celeste A., Fernandez-Capetillo O., Kruhlak M.J., Pilch D.R., Staudt D.W., Lee A., Bonner R.F., Bonner W.M., Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5:2003;675-679.
4. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K.et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl. Acad. Sci. U.S.A. 99:2002;8173-8178.
5. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J.et al. Genomic instability in mice lacking histone H2AX. Science. 296:2002;922-927.
6. •].
7. •].
8. •].
9. 2 checkpoint in response to low dose (but not high dose) of IR. Thus, 53BP1 is either a critical adaptor or a mediator protein for DNA-damage signaling.
10. Ward I.M., Minn K., van Deursen J., Chen J. p53 binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol. Cell Biol. 23:2003;2556-2563.
11. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:2002;285-289.
12. •].
13. •] show that the BRCT-motif-containing protein MDC1 is phosphorylated in an ATM-dependent manner and rapidly localizes to sites of DNA damage in response to IR. Using small interfering RNA-mediated depletion of MDC1, they show that MDC facilitates the recruitment of checkpoint and DNA repair proteins such as BRCA1, thereby contributing to activation of the intra-S checkpoint. Thus MDC1 functions as either an adaptor or mediator protein for transducing signals from DNA damage.
14. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 300:2003;1542-1548.
15. Weiss R.S., Leder P., Vaziri C. Critical role for mouse Hus1 in an S-phase DNA damage cell cycle checkpoint. Mol. Cell Biol. 23:2003;791-803.
16. Zou L., Cortez D., Elledge S.J. Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev. 16:2002;198-208.
17. Lukas C., Falck J., Bartkova J., Bartek J., Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5:2003;255-260.
18. Goldberg Z., Vogt Sionov R., Berger M., Zwang Y., Perets R., Van Etten R.A., Oren M., Taya Y., Haupt Y. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J. 21:2002;3715-3727.
19. Xu X., Tsvetkov L.M., Stern D.F. Chk2 activation and phosphorylation- dependent oligomerization. Mol. Cell Biol. 22:2002;4419-4432.
20. Ahn J.Y., Li X., Davis H.L., Canman C.E. Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain. J. Biol. Chem. 277:2002;19389-19395.
21. ••].
22. •• ] show that Chk2 is essential for IR-induced, p53-mediated apoptosis and regulates both the trans-activation activity and stability of p53 in response to IR.
23. Falck J., Lukas C., Protopopova M., Lukas J., Selivanova G., Bartek J. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene. 20:2001;5503-5510.
24. Falck J., Petrini J.H., Williams B.R., Lukas J., Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30:2002;290-294.
25. Zhao H., Watkins J.L., Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. U.S.A. 99:2002;14795-14800.
26. Sorensen C.S., Syljuasen R.G., Falck J., Schroeder T., Ronnstrand L., Khanna K.K., Zhou B.B., Bartek J., Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell. 3:2003;247-258.
27. Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y., Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16:2002;571-582.
28. Kim S.T., Xu B., Kastan M.B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 16:2002;560-570.
29. 2 arrest. Checkpoint activation by either stalled or incomplete DNA replication does not depend on an ATR-Chk1 pathway in mammalian cells.
30. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G.et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4:2002;11-19.
31. Hofmann T.G., Moller A., Sirma H., Zentgraf H., Taya Y., Droge W., Will H., Schmitz M.L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4:2002;1-10.
32. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell. 11:2003;577-590.
33. Dumont P., Leu J.I., Della Pietra A.C. III, George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33:2003;357-365.
34. Stevens C., Smith L., La Thangue N.B. Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 5:2003;401-409.
35. Yang S., Kuo C., Bisi J.E., Kim M.K. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat. Cell Biol. 4:2002;865-870.
36. ••].
37. 1-S checkpoint to allow DNA repair or apoptosis is important for tumor suppression.
38. ••].
39. ••] show that H2AX haploinsufficiency causes genomic instability in either normal or p53-deficient cells and increases susceptibility to cancer in the absence of p53, indicating that H2AX as a genomic caretaker and p53 as a gatekeeper cooperate to protect against tumorigenesis.
40. Brown K.D., Rathi A., Kamath R., Beardsley D.I., Zhan Q., Mannino J.L., Baskaran R. The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 33:2003;80-84.
41. Franchitto A., Pichierri P., Piergentili R., Crescenzi M., Bignami M., Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene. 22:2003;2110-2120.